Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

HALOZYME THERAPEUTICS, INC. (HALO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Revenues          
Total revenues  221.0162.1209.0152.4117.3102.0115.8136.5
            Total revenues growth  45.1%38.3%80.4%11.7%31.7%-16.2%77.3%147.1%
Operating expenses          
Cost of sales  50.135.247.333.915.921.618.623.0
Amortization of intangibles  17.817.827.211.4    
Research and development  19.718.016.715.511.910.18.58.1
Selling, general and administrative  38.937.434.557.513.813.813.212.3
    Total operating expenses  126.6108.3125.7118.341.645.540.243.4
    Operating income  94.553.883.334.175.756.575.693.0
            Operating margin  42.7%33.2%39.9%22.4%64.5%55.4%65.3%68.2%
   
Other income (expense)          
Investment and other income (expense), net  3.23.00.6-0.90.50.30.30.2
Interest expense  -4.5-4.5-7.5-3.1-1.8-2.1-1.8-1.8
    Net income before income taxes  93.252.273.730.074.454.874.191.5
Income tax expense  18.412.612.17.314.3-12.0-142.50.1
    Net income  74.839.661.622.760.166.8216.691.5
   
Earnings per share          
Basic (USD per share)  $0.57$0.29$0.45$0.16$0.44$0.47$1.53$0.64
Diluted (USD per share)  $0.56$0.29$0.44$0.16$0.43$0.46$1.48$0.62
   
Weighted average common shares outstanding          
Basic (shares)  131.7135.0136.5137.9137.7140.6142.0142.5
Diluted (shares)  133.5137.9139.4142.2141.3146.8146.7147.6

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy